Vivienne has over 18 years’ experience in commercialisation of analytical and life science tools. In 2023, following an offer from a US company to acquire Cellix; Vivienne negotiated the sale of Cellix to Randox, a diagnostics company based in Northern Ireland. Vivienne now works closely with Randox R&D teams, transferring Cellix’s knowledge in microfluidics to adapt, develop and improve their biochip offering for diagnostics.